General Procedures
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13 C NMR spectra were recorded at room temperature on a Bruker Avance 500 instrument operating at a frequency of 500 MHz for 1 H and 125 MHz for 13 C. 1 H NMR spectra were referenced to the CDCl 3 (7. 26 ppm) signal. 13 C NMR spectra were referenced to the CDCl 3 (77.67 ppm) signal. Infra-red spectra were run on a PerkinElmer Spectrum 100 FT-IR spectrometer operating in ATR mode with frequencies given in reciprocal centimeters (cm -1 ). Mass spectra and high resolution mass data for small molecules were recorded on a VG70-SE mass spectrometer (EI mode). Melting points were taken on a Gallenkamp heating block and are uncorrected. Lyophilised somatostatin, 3,4-dibromomaleimide, N-methylmaleamic acid and Nphenylmaleamic acid were purchased from Sigma-Aldrich and used without further purification. N-Phenylbromomaleimide 1 , N-phenyldibromomaleimide 2 , Nmethylbromomaleimide 3 and N-fluoresceindibromomaleimide 3 were synthesized as described previously.
Protein / Peptide Mass Spectrometry
LC-MS was performed on protein samples using a Waters Acquity uPLC connected to Waters Acquity Single Quad Detector (SQD). Column: Acquity uPLC BEH C18 1. The electrospray source of the MS was operated with a capillary voltage of 3.5 kV and a cone voltage of 50 V. Nitrogen was used as the nebulizer and desolvation gas at a total flow of 600 L/h.Total mass spectra for protein samples were reconstructed from the ion series using the MaxEnt 1 algorithm pre-installed on MassLynx software. Monobromomaleic anhydride (45.0 mg, 0.25 mmol, 1 eq) was added in one portion to a solution of 2-(2-(2-(5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno(3,4-d)imidazol-6-yl)pentanoylamino)ethoxy)ethoxy)ethylammonium 2,2,2-trifluoroacetate 4 (124 mg, 0.25 mmol, 1 eq) in acetic acid (10 mL) and the reaction mixture heated to 170 °C for 3 h. Upon cooling to 21 °C toluene was added and the acetic acid azeotropically removed in vacuo (x2) to give crude product. Column chromatography (gradient 2-10% MeOH/CH 2 Cl 2 ) yielded 11 as a white solid (70.0 mg, 0.13 mmol, 52% yield 
Synthesis of Cleavable Affinity Tag 11.
N-(2-(2-(2-(3-bromo-2,5-dioxo-pyrrol-1-yl)ethoxy)ethoxy)ethyl)-5-(2-oxo-
Protein and Peptide Modification
Sequence of isolated Grb2-SH2 L111C (residues 53-163) 1:
Calculated mass = 14168
Cloning and Expression of Grb2-SH2 L111C Mutant 1
SH
The DNA construct for the Grb2 SH2 domain contained the primary amino acid sequence 53-163 and was cloned on plasmid QE-60 (Qiagen). 5 The Grb2 SH2 L111C mutant was constructed by site-directed mutagenesis (Stratagene Kit) using oligonucleotides coding for the mutated residue. Both constructs were expressed in Escherichia coli (M15[pREP4], Qiagen) using a T5 promoter and a C-terminal 6-His
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Tag was incorporated to aid purification. Cultures (1 L) were grown at 37 0 C in Terrific Broth. from a single colony, and expression was induced with 1.0 mM isopropyl β-D-1-thiogalactopyranoside when an O.D. λ600 of 0.9 was attained. Cultures were allowed to express protein for 3 h before the cells were pelletised. Pellets were lysed in 0.1M sodium phosphate, 300 mM NaCl, 50 mM imidazole, pH 7.2 containing a protease inhibitor cocktail (Roche). The lysate was centrifuged, and the supernatant was applied to a Ni-NTA column (Qiagen). Grb2-SH2 L111C was eluted from the Ni-NTA column with 0.1M sodium phosphate, 300 mM NaCl, 200 mM imidazole at pH 7.2 . The collected Grb2 SH2 L111C 1 was ~95% pure as visualized by Coomassie-stained SDS-PAGE. Dimerization of Grb2 SH2 domain through domain-swapping has been previously observed. 6 Dimeric and monomeric Grb2-SH2 were separated on a Sephacryl S-100 column (320 mL) that had been pre-equilibrated with 0.1 M sodium phosphate and 150 mM NaCl at pH 8.0. Two peaks eluted, corresponding to the molecular weights of monomer (~14 kDa) and dimer (~28 kDa) Grb2-SH2. Almost, 60% of the Grb2-SH2 L111C domain 1 eluted from the column as monomer. Separated monomer and dimer were found to be surprisingly kinetically stable, as very little interconversion was seen over a course of months at 4 0 C. The monomer was concentrated using Amicon® Ultra-4 centrifugal filter units (Millipore) and the final concentration of the protein was determined by absorbance at 280nm using the extinction coefficient obtained by McNemar and coworkers (15,600M -1 ).
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The protein was frozen at 2 mg/mL concentration in 100 μL aliquots which were thawed as required for experiments.The mass of the monomeric protein 1 (mass = 14177) was obtained using LC-MS S4 To a solution of model protein 1 (100 μL, [Protein] 2.0 mg/mL, 100 mM sodium phosphate, 150 mM NaCl, pH 8.0) at 0 o C was added N-methylmaleamic acid (5 μL, 2.82 mM solution in DMF). The mixture was vortexed for 1 s then maintained at 0 o C for 2 h. Analysis using LC-MS showed that no reaction had occurred. Heating the reaction at 37 o C for a further 2 h also yielded no conversion.
Reaction of Grb2-SH2 Domain L111C with N-Phenylmaleamic Acid
To a solution of model protein 1 (100 μL, [Protein] 2.0 mg/mL, 100 mM sodium phosphate, 150 mM NaCl, pH 8.0) at 0 o C was added N-phenylmaleamic acid (5 μL, 2.82 mM solution in DMF). The mixture was vortexed for 1 s then maintained at 0 o C for 2 h. Analysis using LC-MS showed that no reaction had occurred. Heating the reaction at 37 o C for a further 2 h also yielded no conversion. To a solution of model protein 1 (100 μL, [Protein] 2.0 mg/mL, 100 mM sodium phosphate, 150 mM NaCl, pH 8.0) at 0 o C was added N-methylbromomaleimide (5 μL, 2.82 mM solution in DMF). The mixture was vortexed for 1 s then maintained at 0 o C for 1 h. Analysis using LC-MS showed that the desired product had been formed in quantitative conversion (mass = 14288) 3 .
The solution of Grb2-SH2 domain L111C / N-methylbromomaleimide adduct was heated at 37 o C for 4 h. The construct was stable to hydrolysis under these conditions (mass = 14289). To a solution of model protein 1 (100 μL, [Protein] 2.0 mg/mL, 100 mM sodium phosphate, 150 mM NaCl, pH 8.0) at 0 o C was added N-phenylbromomaleimide 2 (5 μL, 2.82 mM solution in DMF). The mixture was vortexed for 1 s then maintained at 0 o C for 1 h. Analysis using LC-MS showed that protein / N-phenylbromomaleimide adduct 3 had been formed (mass = 14351).
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Heating of the mixture at 37 o C for 4 h gave the desired product 4 in quantitative conversion (mass = 14369).
Treatment of Hydrolysed Grb2-SH2 Domain L111C / NPhenylbromomaleimide Adduct 4 with excess 2-Mercaptoethanol
To a solution of model protein 1 (100 μL, [Protein] 2.0 mg/mL, 100 mM sodium phosphate, 150 mM NaCl, pH 8.0) at 0 o C was added N-phenylbromomaleimide 2 (5 μL, 2.82 mM solution in DMF). The mixture was vortexed for 1 s then maintained at 0 o C for 1 h. Analysis using LC-MS showed that protein / N-phenylbromomaleimide adduct 3 had been formed (mass = 14351).
Heating of the mixture at 37 o C for 4 h gave the desired product 4 (mass = 14369).
The mixture was treated with 2-mercaptoethanol (5 μL, 282 mM solution in H 2 O), vortexed for 1 s and maintained at 37 o C for 4 h after which the mixture was analysed by LC-MS. Analysis showed that hydrolysed protein / N-phenylbromomaleimide adduct 4 was stable to these conditions. To a solution of model protein 1 (100 μL, [Protein] 2.0 mg/mL, 100 mM sodium phosphate, 150 mM NaCl, pH 8.0) at 0 o C was added N-phenyldibromomaleimide 5 (5 μL, 2.82 mM solution in DMF). The mixture was vortexed for 1 s then maintained at 0 o C for 2 h. Analysis using LC-MS showed that a mixture of the expected product 6 (mass = 14427) and its hydrolysed derivative 7 (mass = 14445) had been formed in a 7:3 ratio. 
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To a solution of model protein 1 (100 μL, [Protein] 2.0 mg/mL, 20 mM MES, 150 mM NaCl, pH 6) at 0 o C was added N-phenyldibromomaleimide 5 (5 μL, 2.82 mM solution in DMF). The mixture was vortexed for 1 s then maintained at 0 o C for 2 h. Analysis using LC-MS showed that the desired product 6 had been formed in >95% conversion (mass = 14427).
The mixture was treated with Ellman's reagent (5 μL, 282 mM solution in H 2 O) at 0 o C. The mixture was vortexed for 1 s and maintained at 0 o C for 10 mins after which the mixture was analysed by LC-MS. Analysis showed that no reaction with Ellman's reagent was evident highlighting that N-phenyldibromomaleimide functionalisation had occurred at C111. The mixture was treated with β-1-thioglucose, sodium salt 8 (5 μL, 2.82 mM solution in H 2 O) at 0 o C. The mixture was vortexed for 1 s and maintained at 0 o C for 1 h after which the mixture was analysed by LC-MS. Analysis showed that the desired product 9 ( mass = 14542) was formed in >90% conversion. The mixture was treated with β-1-thioglucose, sodium salt 8 (5 μL, 2.82 mM solution in H 2 O) at 0 o C. The mixture was vortexed for 1 s and maintained at 0 o C for 1 h after which the mixture was analysed by LC-MS. Analysis showed that the desired product 9 ( mass = 14542) was formed.
The mixture was treated with 2-mercaptoethanol (5 μL, 282 mM solution in H 2 O) at 0 o C. The mixture was vortexed for 1 s and maintained at 0 o C for 2 h after which the mixture was analysed by LC-MS. Analysis showed that the protein / Nphenyldibromomaleimide / β-1-thioglucose 9 had been cleanly cleaved yielding the Grb2-SH2 (L111C) 1 ( mass = 14177) in quantitative conversion. The mixture was treated with Ellman's reagent (5 μL, 282 mM solution in H 2 O) at 0 o C. The mixture was vortexed for 1 s and maintained at 0 o C for 10 mins after which the mixture was analysed by LC-MS. Analysis showed that no reaction with Ellman's reagent was evident highlighting that biotinylation had occurred at C111.
2-Mercaptoethanol-mediated Cleavage of Grb2-SH2 Domain L111C / Biotin-PEG-bromomaleimide Adduct 12 to Yield Protein 1
SH
To a solution of model protein 1 (100 μL, [Protein] 2.0 mg/mL, 100 mM sodium phosphate, 150 mM NaCl, pH 8.0) at 0 o C was added biotin-PEG-bromomaleimide 11 (5 μL, 2.82 mM solution in DMF). The mixture was vortexed for 1 s then maintained at 0 o C for 1 h. Analysis using LC-MS showed that the protein / biotin-PEGbromomaleimide adduct 12 had been formed (mass = 14630).
The mixture was treated with 2-mercaptoethanol (5 μL, 282 mM solution in H 2 O), vortexed for 1 s and maintained at 37 o C for 4 h after which the mixture was analysed S15 by LC-MS. Analysis showed that desired product 1 was formed in quantitative conversion ( mass = 14177).
Pull-Down and Release of Grb2-SH2 Domain L111C / Biotin-PEGbromomaleimide Adduct onto Neutravidin Coated Agarose Beads
To a solution of model protein 1 (200 μL, [Protein] 1.0 mg/mL, 100 mM sodium phosphate, 150 mM NaCl, pH 8.0) at 0 o C was added biotin-PEG-bromomaleimide 11 (10 μL, 2.82 mM solution in DMF). The mixture was vortexed for 1 s then maintained at 0 o C for 1 h. Analysis using LC-MS showed that the desired product 12 had been formed (mass = 14630).
Protein / biotin-PEG-bromomaleimide adduct 12 (200 μL) and unmodified model protein 1 (200 μL) were washed independently with PBS buffer (3 x 500 μL), to remove any excess reagent 11, in a concentrator (Vivaspin, cut off 10k) yielding protein solutions (300 μL) (Input fraction, In). For each of the protein solutions obtained, neutravidin-coated agarose beads (Pierce) (750 μL of 50% aqueous slurry ) were washed with PBS (2 x 500 μL). Protein solution (300 μL) was then added to the beads and the mixture incubated at 4 o C for 30 mins. The mixture was centrifuged and the flow through (FT) collected. The beads were washed with PBS (2 x 500 μL) and both wash fractions collected (W1 and W2). Protein was released from the beads by incubation in PBS (300 μL) containing 2-mercaptoethanol (25 mM) for 2 h at 37 o C. The sample was centrifuged and the eluant (El) containing cleaved Grb2-SH2 domain L111C collected. The amount of protein recovered was determined as 46% by comparison with a protein series dilution on a SDS-PAGE gel via densitometry. However, correcting for non-specific, irreversibly bound protein (determined using the unmodified protein control) the corrected recovery was 77%. Lyophilised somatostatin (Sigma-Aldrich) was solubilised in buffer (50 mM sodium phosphate, pH 6.2, 40 % ACN, 2.5 % DMF) to yield a concentration of 152.6 μM (0.25 mg/ml) and reduced with TCEP (1.1 eq) for 1 h at ambient temperature. After the completeness of the reduction had been confirmed by LC-MS (M +2 = 820), Nfluorescein-dibromomaleimide (1.1 eq) was added for 10 min at room temperature and quantitative insertion of the maleimide into the opened disulfide bond to give 13 was confirmed by LC-MS (M +2 = 1033).
Hydrolysed
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The solution of conjugate 13 was dialysed (sodium phosphate, 50 mM, pH 8) (Slide-A-Lyzer 2-Mercaptoethanol (100 mol eq.) was added and the reaction was maintained at 37°C for 24 h. Analysis by LC-MS showed that the hydrolysed somatostatin / N-fluorescein dibromomaleimide adduct 14 was completely stable to these reaction conditions. The mixture was treated with 2-mercaptoethanol (5 μL, 282 mM solution in H 2 O) at 0 o C. The mixture was vortexed for 1 s and maintained at 37 o C for 4 h after which the mixture was analysed by LC-MS. Analysis showed that hydrolysed protein / Nfluoresceindibromomaleimide / β-1-thioglucose 15 adduct was stable to these conditions.
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